The global hematology diagnostic market is projected to grow from USD 780.0 million in 2023 to USD 2.0 billion by 2033, at a ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

A recent study provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that saliva contains ...

A recent study showed administering certain types of blood to RhD-negative patients could help conserve blood supplies during ...

FlowScore is a new, cost-effective metric for assessing red blood cell quality, improving oxygen delivery evaluation in blood ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...

Cell therapies — particularly chimeric antigen receptor T-cell (CAR T) therapies — have shown remarkable efficacy in treating ...